Related Experiment Videos
Pharmacological intervention in renal fibrosis and vascular sclerosis
G J Becker1, V Perkovic, T D Hewitson
1Department of Nephrology, The Royal Melbourne Hospital, Vic., Australia. Gavin.Becker@mh.org.au
Abstract:
Progressive renal disease is associated with the development of fibrosing lesions not only in the glomerulus, but also in the interstitial and vascular compartments of the kidney. A growing body of work suggests that the mechanisms involved in this process are to a large extent shared by the glomerular mesangial cell, tubulointerstitial fibroblast and vascular smooth muscle cell. In this review we consider evidence that treatment strategies focused on any one of these cells are likely to be of universal benefit in the abrogation of the ongoing scarring that accompanies progressive renal disease, while at the same time reducing the progressive vascular sclerosis so often ultimately responsible for the excessive mortality seen in patients with renal failure.
Insights
Targeting shared cellular mechanisms in progressive renal disease may universally reduce kidney scarring and vascular sclerosis. This approach could improve outcomes for patients with kidney failure.
Area of Science:
- Nephrology
- Pathology
- Cell Biology
Background:
- Progressive renal disease involves fibrotic lesions in glomerular, interstitial, and vascular kidney compartments.
- Glomerular mesangial cells, tubulointerstitial fibroblasts, and vascular smooth muscle cells share common fibrotic mechanisms.
Purpose of the Study:
- To review evidence supporting shared cellular mechanisms in kidney fibrosis.
- To explore the potential of targeting these shared mechanisms for therapeutic benefit in progressive renal disease.
Main Methods:
- Literature review of studies on renal fibrosis and cellular mechanisms.
- Analysis of evidence linking glomerular, interstitial, and vascular cell behavior in kidney disease.
Main Results:
- Evidence suggests common pathways drive fibrosis across different kidney compartments.
- Targeting shared cellular processes may offer a unified strategy against renal scarring.
Conclusions:
- Therapeutic strategies focused on common cellular mechanisms hold promise for treating progressive renal disease.
- Such approaches could mitigate kidney scarring and reduce vascular complications, improving patient survival.